Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?
Referência bibliográfica :
Panteleimon E Papakonstantinou, Josip A Borovac, Aleksandra Gąsecka, Dario Bongiovanni, Hanne Ehrlinder, Michela Giustozzi, William A E Parker, Rui Azevedo Guerreiro
Descrição sumária: